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Background. Regret-based decision curve analysis (DCA) is a framework that assesses the medical
decision process according to physician attitudes (expected regret) relative to disease-based factors. We
sought to apply this methodology to decisions around the operative management of intrahepatic
cholangiocarcinoma (ICC).
Methods. Utilizing a multicentric database of 799 patients who underwent liver resection for ICC, we
developed a prognostic nomogram. DCA tested 3 strategies: (1) perform an operation on all patients, (2)
never perform an operation, and (3) use the nomogram to select patients for an operation.
Results. Four preoperative variables were included in the nomogram: major vascular invasion
(HR = 1.36), tumor number (multifocal, HR = 1.18), tumor size (>5 cm, HR = 1.45), and suspicious
lymph nodes on imaging (HR = 1.47; all P < .05). The regret-DCA was assessed using an online survey
of 50 physicians, expert in the treatment of ICC. For a patient with a multifocal ICC, largest lesion
measuring >5 cm, one suspicious malignant lymph node, and vascular invasion on imaging, the
1-year predicted survival was 52% according to the nomogram. Based on the therapeutic decision of the
regret-DCA, 60% of physicians would advise against an operation for this scenario. Conversely, all
physicians recommended an operation to a patient with an early ICC (single nodule measuring 3 cm, no
suspicious lymph nodes, and no vascular invasion at imaging).
Conclusion. By integrating a nomogram based on preoperative variables and a regret-based DCA, we
were able to define the elements of how decisions rely on medical knowledge (postoperative survival
predicted by a nomogram, severity disease assessment) and physician attitudes (regret of commission and
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URGERYINTRAHEPATIC CHOLANGIOCARCINOMA (ICC) accounts
for 10–15% of all liver cancers and after hepatocel-
lular carcinoma, is the second most common pri-
mary liver malignancy.1,2 An operation remains
the sole curative treatment for ICC; however, only
30–40% of patients present with resectable disease
at the time of diagnosis.3 High recurrence rates
and inefficient adjuvant chemotherapy regimens
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from 14–40%.4,5 In fact, a multicentric interna-
tional study of patients with ICC reported that up
to 25% of patients presented with resectable dis-
ease and had a median postoperative overall sur-
vival of only 14.8 months.6
These survival data are not too dissimilar to a
recent phase 3, randomized control trial of pa-
tients with advanced unresectable ICC, who
achieved a median survival of 11.7 months with
the use of combination gemcitabine and cisplatin
chemotherapy.7 As such, it appears that a subset of
patients may derive little to no additional survival
benefit from liver resection compared with chemo-
therapy alone, while at the same time being
exposed to the risk of postoperative morbidity.8,9
Data on the cost-effectiveness of upfront hepatic
resection versus initial systemic chemotherapy fol-
lowed by possible curative hepatic resection
further underline the need for more precise guide-
lines on the operative management of patients
with advanced ICC.10
Given the complexity and challenges involved in
decision-making around the management of pa-
tients with ICC, traditional decision-making utility
models may be inadequate. In utility theory, the
axiom of decision analysis requires that the physi-
cian make decisions based on maximizing the
expected utility outcome (eg, prolongation of
patient survival) but does not allow for any
estimation of the uncertainty in achieving that
outcome. In reality, however, a physician’s choice
of therapy may depend greatly on the amount of
uncertainty surrounding the likelihood of
achieving the outcome.11 For example, after mak-
ing a decision that involves some uncertainty, the
physician may discover, when learning the relevant
outcomes, that an alternative approach would have
been preferred---thereby bringing about a sense of
regret. In particular, a physician might have
preferred to avoid certain consequences (eg, post-
operative complications) in which he/she comes
to realize that the desired outcome (eg, long-
term survival) was not achieved.12
In contrast to utility-based theory, regret-based
decision methodology is a framework that inte-
grates medical knowledge and physician attitudes
(expected regret) when outcomes have a level of
uncertainty.13,14 In regret theory, the decision
maker relies on a combination of rationality and
intuition, expecting that some outcomes will be
associated with high regret, which he / she would
like to avoid.12,13,15-17 In this model of decision-
making, the optimal choice would be the one asso-
ciated with the least amount of regret.In the current study, we sought to apply regret-
based decision curve analysis (regret-DCA) to
different treatment strategies for patients present-
ing with ICC. Specifically, we assessed if decisions
regarding whether to perform an operation or
treat with chemotherapy alone can be aided by a
prognostic model derived from a large, multi-
center, international cohort of patients with ICC,
depending on regret-based thresholds. Further-
more, we sought to compare the actual attitudes
of providers using a case-based survey versus the
results of the regret-DCA model.MATERIALS AND METHODS
Data sources and study population. Data on
patients with histologically confirmed ICC were
obtained from an international, multi-institutional
database of 799 patients who underwent a liver
operation between 1990 and 2013 at 14 major
hepatobiliary centers (Johns Hopkins Hospital,
Baltimore, MD; Medical College of Wisconsin,
Milwaukee, WI; Stanford University, Stanford, CA;
University of Virginia, Charlottesville, VA; Emory
University, Atlanta, GA; University of Pittsburgh,
Pittsburgh, PA; Fundeni Clinical Institute of Diges-
tive Disease, Bucharest, Romania; Curry Cabral
Hospital, Lisbon, Portugal; Hopitaux Universi-
taires De Geneve, Geneva, Switzerland; Ospedale
San Raffaele, Milan, Italy; University of Sydney,
Sydney, Australia; Eastern Hepatobiliary Surgery
Hospital, Shanghai, China; Ospedale GB Rossi,
University of Verona, Italy; Ospedale S. Orsola,
University of Bologna, Italy).
Patients presenting with metastatic disease at
the time of diagnosis (American Joint Committee
on Cancer Stage IVB) were excluded from the
study cohort. Similarly, patients who underwent a
palliative resection or patients treated with percu-
taneous ablation were excluded from the study
population. Data were collected on a wide range of
demographic, clinical, and therapeutic factors as
described earlier.6
Statistical analysis and development of the
predictive model. Survival curves were estimated
using the Kaplan-Meier method, and differences
between curves were investigated using the log-
rank test. A new model to predict overall survival
after an operation was created by analyzing patient
and tumor characteristics. Preoperative variables
that were statistically significant in the univariable
analysis were tested in multivariable analyses using
a Cox proportional hazards regression model.
Using a backward elimination method based on
the Akaike Information Criterion (AIC), variables
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model. A P value of .10 was the threshold for inclu-
sion of variables in the multivariable model.
Point estimates for variables obtained from the
multivariable model were reported as hazard ratios
(HR) with corresponding 95% confidence inter-
vals (CI).
A nomogram to predict survival of patients with
ICC undergoing operative resection was built
using the results of the multivariable analysis.
Specifically, the preoperative variables that were
statistically significant in both the univariate and
multivariable analyses were included in the nomo-
gram. The nomogram was developed using the
package of Hmisc in R version 3.11.0 (http://www.
r-project.org/). The concordance index (C-index)
was used to assess the performance of the nomo-
gram, while the calibration of the nomogram was
evaluated by comparing nomogram-predicted
versus observed Kaplan-Meier estimates of survival
probability. Bootstrap with 5,000 resample was
used for these analyses.
Regret-based decision analysis. In the regret-
DCA, the decision was analyzed comparing the
probability of an outcome (eg, probability of sur-
vival [S]) with a regret threshold probability (Preg)
based on the physician attitudes. The S was
estimated using the nomogram including relevant
preoperative clinicopathologic variables. Preg was
estimated using Equation 1:
Equation 1 for Preg :
1
1þ Regret of Omission
Regret of Commision
Regret of omission was defined as the regret felt
by the physician who decided not to perform an
operation on a patient with ICC, even if he/she
might have benefited from the treatment.
Conversely, regret of commission was defined as
the regret felt by the physician who decided to
perform an operation on a patient, even if he/she
might not have gained any benefit from the
treatment.13-15
The results of the DCA analyses were assessed
using the probability of survival at different time
points (1, 2, and 3 years). In other words, we
considered the hypothesis that different physicians
might have different opinions on what survival
time point would be relevant in deciding whether
to offer a patient resection for ICC. Consequently,
we evaluated the overall S calculated at 1, 2, and
3 years in relation to the Preg expressed by the
physician. In the DCA model, an operation should
be offered to patients if the patient’s S was equal to
or above the Preg (S$ Preg), because this decisionwould be associated with the least amount of
regret.
Regret associated with the treatment choice
was analyzed using 3 different strategies: (1) a
physician could perform operations on all pa-
tients with technically resectable ICC; (2) a
physician could decide to treat all patients with
chemotherapy and advise against performing an
operation in any patient; or (3) a physician could
use the prediction model (nomogram) to select
patients for an operation. Any of these strategies
may result in regret if the patient’s survival is less
than expected by the physician, while the optimal
strategy would be the one associated with the least
amount of regret when proven to be wrong
(S < Preg).
Using the decision tree reported by Djulbegovic
et al11,12 (Fig 1), regret was expressed as the differ-
ence between the utility of the outcome of the
treatment selected and the utility of the outcome
of the action that, retrospectively, should have
been taken:








Equation 3; Expected regret for performing an





Equation 4; Expected regret for performing no
operation on all patients : S
where false positive was the number of patients
who died within a specific temporal endpoint (1, 2,
and 3 years) and for whom S > Preg; false negative
was the number of patients who will survive longer
than a specific temporal end point (1, 2, and
3 years) and for whom S < Preg; n was the number
of patients and S was the overall survival probabil-
ity at a specific temporal end point. All analyses
were performed using STATA version 12.0 (Stata-
Corp LP, College Station, TX) or R software for sta-
tistical computing (R Foundation, Vienna,
Austria), v. 3.0.2 34, with the additional packages:
survival and Hmisc.18-20
Description of the survey. To further explore
the regret-DCA, an online survey was administered
to examine the regret associated with treatment
decisions for the 3 hypothetical ICC cases. The
survey was administered to a convenience sample
of 50 physicians with expertise in the treatment of
ICC. Respondents were asked to report an estima-
tion of their regret of commission and omission on
Fig 1. The decision tree for recommending an operation to ICC patients.
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consisted of a 65-year-old man, American Society
of Anesthesiologists score II with well-controlled
hypertension, normal hepatic function, and no
history of chronic liver disease. The computed
tomography (CT) scan performed for abdominal
pain showed a nonmetastatic, operatively resect-
able ICC. For the purpose of each case, the
physician assumed the patient was willing to pro-
ceed with the therapy recommended and had no
preference for operative or nonoperative therapy.
Three different cases were described: Case 1: CT
demonstrated one nodule measuring 5 cm located
in liver segment 8, one possible metastatic peri-
hilar lymph node, no invasion of major vessels.
Case 2: CT demonstrated one nodule measuring
3 cm located in liver segment 3, no suspicious
lymph nodes, no invasion of major vessels. Case 3:
CT scan demonstrated 3 nodules, the largest
measuring 6 cm, located in liver segments 5 and
8, one perihilar lymph node highly suspicious for
metastasis, and vascular invasion of the right
branch of the portal vein. Moreover, for each
case, the physician was asked to answer the
following question: “When you suggest surgery to
this patient, what do you think would be an
acceptable minimal survival for him/her after
surgery (ie, a survival time after which you wouldnot experience regret for having decided to
operate)?”RESULTS
Baseline characteristics. The clinicopathologic
characteristics of 799 patients who underwent liver
resection for ICC are presented in Table I. The ma-
jority of patients were male (n = 425; 53.2%), and
the median age at diagnosis was 61.7 years (inter-
quartile range [IQR] 52.0–70.1). On preoperative
assessment, median CA 19-9 was 87.8 U/mL
(IQR, 16.9–500.0); 188 (23.5%) patients had
lymph nodes suspicious for metastasis (ie, >1 cm,
enhancing, etc); and 142 (17.8%) patients had ma-
jor vascular invasion on imaging (Table I); 79
(9.9%) patients had underlying chronic liver
disease.
A total of 315 (39.4%) patients had multifocal
disease; median tumor size was 6.5 cm (IQR, 4.6–
9.0), and 516 (64.6%) patients had a tumor >5 cm.
At the time of the operation, hepatic resection
consisted of a minor (#3 liver segments, n = 277;
34.7%) or a major (>3 liver segments, n = 522;
65.3%) hepatectomy. On the final pathologic
report, most patients had a well-differentiated tu-
mor (n = 574, 71.8%), while fewer had a moder-
ately/poorly differentiated tumor (n = 225,
Table I. Baseline characteristics of the 799 patients
who underwent liver resection for intrahepatic
cholangiocarcinoma between 1990 and 2013
N (%)
Age (y), median (IQR) 61.7 (52.0–70.1)
Gender, male 425 (53.2)
Cirrhosis, present 79 (9.9)
Margin Status, positive 167 (20.9)
Number of Tumors, multifocal 315 (39.4)
Tumor Size (cm), median (IQR) 6.5 (4.6–9.0)
Tumor Size, $5 cm 516 (64.6)
Tumor Grade, moderate/poor 225 (28.2)









Perineural Invasion 228 (28.5)
Invasion of Adjacent Organs,
present
113 (14.1)
CA19-9 (U/mL), median (IQR) 87.8 (16.9–500.0)








1 y 77.6 (74.7–80.6)
2 y 56.0 (52.5–59.8)
3 y 41.4 (37.7–45.3)
4 y 30.6 (27.0–34.6)
5 y 25.2 (21.7–29.2)
CI, Confidence interval; IQR, interquartile range; Preop, preoperative.
Surgery
July 2016
110 Bagante et al28.2%). Microscopic vascular invasion (n = 301,
37.7%) and perineural invasion (n = 228, 28.5%)
were also noted in a subset of patients.
Survival analysis and development of the prog-
nostic model. With a median follow-up of
20.1 months (IQR, 10.6–38.7), 511 (63.9%) pa-
tients died. The 1-, 2-, and 3-year survival was
77.6% (95% CI, 74.7–80.6), 56.0% (95% CI, 52.5–
59.8), and 41.4% (95% CI, 37.7–45.3), respectively.
Demographic and tumor characteristics were
examined for their association with survival
following resection of ICC (Table II). Performing
a stepwise model selection by AIC (backward selec-
tion) for the Cox proportional hazards regression
model, 4 preoperative variables were found to be
strongly associated with overall survival following
resection: lymph nodes suspicious for metastatic
disease (HR = 1.47; 95% CI, 1.19–1.81; P < .001),
tumor size (>5 cm; HR = 1.45; 95% CI, 1.19–
1.75; P < .001), major vascular invasion(HR = 1.36; 95% CI, 1.08–1.73; P = .010), and num-
ber of tumors (multifocal disease, HR = 1.18; 95%
CI, 0.98–1.42; P = .072).
Using these preoperative factors, a nomogram
was constructed to predict postoperative overall
survival following liver resection of ICC (Fig 2).
Based on the different beta coefficients, each fac-
tor was assigned a weighted number of points in
the nomogram. The sum of points for each patient
was associated with a specific predicted 1-, 2- and
3-year overall survival, with a higher score being
associated with a worse prognosis. Discrimination
ability of the final model for overall survival was as-
sessed using the c-statistic, with a bootstrapping re-
sample method (n = 5,000) yielding an unbiased
c-statistic estimate of 0.59. The calibration plots re-
vealed good prediction of 1-, 2-, and 3-year overall
survival (Supplementary Figs A, B, and C). The pre-
dicted probabilities overlapped with the actual sur-
vival probabilities, suggesting that the model had a
good discrimination ability to distinguish high-risk
from low-risk individuals.
Regret-DCA. Regret-DCA was applied to the 1-,
2-, and 3-year survival predictions. Figure 3, A, B,
and C depicts how the expected regret changed
for different Pregs applied to 1-, 2-, and 3-year sur-
vival predictions. Specifically, these graphs
analyzed the relationship between the Preg and
the expected regret associated with each of the 3
possible therapeutic strategies (ie, treat all patients
with an operation, treat none with an operation,
and use the nomogram to select patients for an
operation).
As depicted in Fig 3, A, for a Preg <75%, the
least regretful strategy was to use the predictive
nomogram model to identify which patients to
offer an operation. In this scenario, a physician
should offer liver resection only to patients with a
predictive survival (estimated by the nomogram)
that was greater than the Preg accepted by the
physician (S > Preg). If the estimated survival
based on the model’s prediction was lower than
the regret probability (S < Preg), then avoiding
an operation and treating with chemotherapy
alone would be the less regretful, and therefore
preferred, strategy.
As such, for a Preg >75%, the preferred, least-
regretful therapeutic strategy would be to withhold
resection and offer chemotherapy alone to all
patients. To demonstrate this point, take for
example, a physician who may calculate his/her
Preg to be 33.3% (regret of omission = 60; regret
of commission = 30). If on preoperative imaging
the patient had a single 6-cm tumor with no major
invasion but suspicious lymph node disease, the
Table II. Uni- and multivariable survival analysis of the clinicopathologic characteristics of patients who
underwent liver resection for intrahepatic cholangiocarcinoma
Univariable analysis Multivariable analysis
HR 95% CI P* HR 95% CI Py
Age, y 1.01 0.99–1.01 .099z
Gender, female 0.81 0.68–0.96 .018z
Cirrhosis, present 1.25 0.94–1.65 .127
Major Vascular Invasion, present 1.56 1.24–1.96 <.001z 1.36 1.08–1.73 .010
Microscopic Vascular Invasion, present 1.21 1.01–1.45 .037
Invasion of Adjacent Organs, present 1.55 1.22–1.97 <.001z
Perineural Invasion, present 1.13 0.93–1.38 .216
Number of Tumors, multiple 1.31 1.10–1.56 .002z 1.18 0.98–1.42 .072
Margins, positive 1.43 1.14–1.79 .001
CA 19-9, >40 U/mL 1.21 1.01–1.46 .041z
Tumor Size, $5 cm 1.46 1.21–1.76 <.001z 1.45 1.19–1.75 <.001
Tumor Grade, moderate/poor 1.31 1.09–1.58 .004
Major Resection, performed 1.26 1.05–1.52 .012
Suspicious Nodes on Preop Imaging, present 1.62 1.33–1.98 <.001z 1.47 1.19–1.81 <.001
Adjuvant Chemotherapy, performed 0.74 0.62–0.88 <.001
*P of the log-rank test comparing two survival curves.
yP of the v2 test comparing the variables in the Cox multivariable model.
zPreoperative variables tested in the multivariable model.
HR, Hazard ratio; CI, confidence interval; Preop, preoperative.
Fig 2. A nomogram, based on 4 preoperative variables, able to predict survival at 1, 2, and 3 years. Each variable cor-
responds to a point (first line), and the sum of the partial points (total points) determines the predictive survival
probability.
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nomogram model would be 66.0%. In this situa-
tion, an operation should be recommended
because the predicted 1-year survival was higher
than the physician threshold of regret (S > Preg),
and therefore, an operation is the least regretful
treatment strategy.However, for a Preg >75%, an operation
should not be recommended regardless of the
model’s prediction, because the regret associated
with the decision to “avoid to perform surgery to
any patients” becomes equal to the regret of
making the choice based on the model. In
addition, given that the highest predicted 1-year
Fig 3. Regret-based decision curves analysis at (A) 1 year,
(B) 2 years, and (C) 3 years after liver resection.
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not be able to support the physician decision-
making process for a Preg above this value.
Figure 3, B and C illustrates how the relation-
ship between expected regret changes for different
Pregs associated with 2- and 3-year overall survival.
If a physician is considering 2-year survival as the
outcome, regret-DCA would suggest that the least
regretful strategy would be to use the predictive
model to recommend patients for an operation
when the Preg is >30%. For values <30%, both
“treat all patients with surgery” and “use a predic-
tive model to select patients who would benefit
from surgery” resulted in lower than expected
regret compared with the strategy “treat no patient
with surgery.” As the highest predicted survival rate
based on the model for 2-year survival was 73%, the
model would not be able to support the physician
decision-making process at any Preg above this
value.Finally, regret-DCA was used to assess decision-
making when 3-year overall survival was used by
the physician as the preferred outcome (Fig 3, C).
When considering 3-year survival, for a Preg
<50%, the least regretful strategy was to treat all
patients with an operation. In contrast, for values
>50%, the treatment decision based on the
model resulted in lower regret. As such, for a
Preg <50%, the least regretful strategy would be
to offer liver resection to patients with a predic-
tive 3-year survival >50%. In contrast, if the Preg
was >50%, the preferred least-regretful therapeu-
tic strategy would be “use a predictive model to
select patients who would benefit from surgery.”
For physicians considering 3-year survival, the
highest predicted survival of the model was
62%, and therefore, the model would not be
able to support the physician in the decision pro-
cess above this threshold.
Survey results. To further assess how physicians
make treatment decisions regarding patients with
ICC, a survey was conducted among 50 physicians
who treat patients with ICC. The survey specifically
sought to assess the range of physician Pregs
associated with 3 different cases characterized
by different predicted survival probabilities
(Table III). While all 50 physicians were able to ex-
press a value for the regret of omission and com-
mission, not every physician believed they could
define an expected survival for the various sce-
narios. As such, there were 110 answers (40 for
case 1, 33 for case 2, and 37 for case 3) defining
the expected survival for the patients in scenarios
1, 2, and 3. In looking at all 3 scenarios, resection
would have been recommended in 82 (74.5%)
cases, whereas no resection and chemotherapy
alone would have been recommended in 28
(25.5%) cases.
For case 1, the hypothetical patient had a total
of 196 points, which resulted in a 1-, 2-, and 3-year
model-predicted survival of 70%, 45%, and 30%,
respectively (Table IV). When actual providers
considered case 1, the reported expected median
patient survival was 2 years (IQR, 1–2), which was
comparable to the predicted survival of 45% at
2 years. Physician respondents reported a median
Preg of 26% (IQR, 12–40). Based on these re-
sponses, both “treat all patients with surgery”
and “use a predictive model to select patients to
treat” would result in low expected regret (Fig 3,
B). Specifically, with an expected survival of 2 years
and a low Preg of 26%, the regret-DCA suggested
that liver resection should be offered to the pa-
tient in case 1. Basing the therapeutic decision
on the regret model, 85% of physicians (34 out
Table III. Results from the survey on the operative
treatment of 3 case scenarios of patients with
intrahepatic cholangiocarcinoma (ICC). A total of
50 physicians with expertise in the treatment of
ICC replied to the survey, reporting for each
patient the supposed expected survival after the
operation and their regret of commission and
omission on a scale ranging from 0 to 100
Median, (IQR)
Case 1
Regret of omission (%) 90 (80–100)
Regret of commission (%) 18 (10–40)
Threshold probability (%) 26 (12–40)
Expected survival (y) 2 (1–2)
Case 2
Regret of omission (%) 100 (100–100)
Regret of commission (%) 1 (1–20)
Threshold probability (%) 5 (4–17)
Expected survival (y) 3 (2–3)
Case 3
Regret of omission (%) 45 (12.5–50)
Regret of commission (%) 50 (20–80)
Threshold probability (%) 54 (30–83)
Expected survival (y) 1 (1–2)
IQR, Interquartile range.
Table IV. Survival predictions based on our




Tumor Size: 5 cm 96
Node Status: 1 suspicious for metastasis 100
Vascular Invasion: No 0








Tumor Size: 3 cm 0
Node Status: 0 suspicious for metastasis 0
Vascular Invasion: No 0








Tumor Size: >5 cm 96
Node Status: 1 suspicious for metastasis 100
Vascular Invasion: Yes 80
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treatment.
For case 2, the median Preg was 5% (IQR, 4–
17). The median reported expected survival was
3 years (IQR, 2–3), which was comparable to the
predicted survival of 55% at 3 years. The use of the
regret-DCA would have led all the physicians (33
out of 33) to decide for hepatic resection.
Regarding case 3, the median Preg was 54%
(IQR, 30–83). The median reported expected
survival was 1 year (IQR, 1–2), which was compa-
rable to the predicted survival of 52% at 1 year,
possibly leading all physicians to decide to prefer
chemotherapy to an operation. Using the predic-
tion model, the patient in case 3 had a total of 319
points, yielding a predicted 1-, 2-, and 3-year
survival of 52%, 30%, and 15%, respectively. With
an expected survival of 1 year and a Preg of 54%,
the regret-DCA would suggest that most physicians
not offer liver resection to this patient. Basing the
therapeutic decision on the regret model, 60% of
physicians (22 out of 37) would have decided for
the same treatment.
DISCUSSION
In the medical setting, classic decision-making
theory defines rationality as aiming to maximize
the outcome that follows a decision to perform aspecific treatment.21 However, this approach to
decision-making analysis is likely inadequate in
those clinical scenarios associated with high levels
of uncertainty, such as the decision to perform
an operation on a patient with ICC. While an oper-
ation benefits many patients with ICC, previous
large multi-institutional studies on patients under-
going liver resection for ICC have described mixed
cohorts of patients, some of whom benefitted from
an operation and others with a prognosis compara-
ble to patients who did not have an operation.6,7
Furthermore, guidelines to assist physicians in
the preoperative selection of patients with ICC
who might benefit the most from liver resection
are lacking.22,23 As such, models considering the
effects that anticipatory regret may have on preop-
erative decision-making can lead to more well-
considered choices.24 Bell et al25 describe regret
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cision, when wrong is determined on the basis of
actual outcomes rather than on the information
available at the time of the decision.” Regret model
theory has been applied to analyze the decision-
making for the operative treatment of other
hepatopancreaticobiliary malignancies such as
hepatocellular carcinoma and pancreatic ductal
adenocarcinoma.13,15,26
Specifically, as noted in the paper by Cucchetti
et al,13 regret theory provides a new perspective for
treatment-related decisions applicable to the clin-
ical setting. The theory explicitly brings to light
the otherwise implicit “biases” or “perspectives”
of different physicians when they are considering
whether to offer therapy to a patient. The theory
helps quantitate the variability in whether the
same patient is offered a specific therapy based
on the different amounts of decisional regret the
provider is willing to tolerate.
In the current paper, we sought to apply regret-
based DCA to the decision-making process in the
setting of the operative treatment of ICC patients.
While integrating medical knowledge with “physi-
cian attitudes” in decision-making occurs during
the everyday practice of performing operations,
this process is implicit and “qualitative.” The
importance of our study is that our model specif-
ically quantifies various elements of decision-
making. In turn, we were able to define how
decisions rely on medical knowledge (postopera-
tive survival predicted by a nomogram, severity
disease assessment) and physician attitudes (regret
of commission and omission). Specifically, we
quantitatively examined the changes in surgeon
regret that can lead to different recommendations.
In essence, we made more explicit the implicit
variation in decisional regret that frequently in-
fluences a surgeon’s willingness to provide an
operation. To this end, we developed and evalu-
ated the performance of a preoperative model to
support physicians in selecting patients who
might benefit the most from hepatectomy. More
importantly, using regret-based DCA, our
approach incorporated a decision maker’s prefer-
ences from the perspective of regret by estimating
a threshold probability for a decision maker. To
our knowledge, this is the first application of
regret DCA to assist surgeons in decision-making
for patients with ICC tumors. The decision
regarding resection for patients with ICC is
particularly well suited for a regret-based
approach, given the general poor prognosis of
this disease leading to the need for personalized
patient care.Two different nomograms have previously been
proposed to predict the prognosis of patients with
ICC following operative resection.6,27 In one study,
Wang et al27 proposed a nomogram that included
serum carcinoembryonic antigen (HR = 1.00), CA
19-9 (HR = 1.01), tumor diameter (HR = 1.07) and
number (2–3 nodules, HR = 1.58; >3, HR = 6.09),
vascular invasion (HR = 1.60), and lymph node
metastasis (HR = 2.05) as well as direct invasion/
local extrahepatic metastasis (HR = 1.59). The au-
thors reported that this model performed well on
internal validation with a C-index of 0.74.
In a separate study, Hyder et al6 proposed a
nomogram that included factors such as age at
diagnosis (HR = 1.31), tumor size (HR = 1.50),
multiple tumors (HR = 1.58), cirrhosis
(HR = 1.51), lymph node metastasis (N1,
HR = 1.78; Nx, HR = 1.29), and vascular invasion
(microscopic, HR = 0.94; macroscopic,
HR = 2.10). This proposed nomogram demon-
strated good predictive abilities with a C-index of
0.69. These nomograms were, however, designed
to be used in the postoperative setting and
included information largely available only on
final operative pathologic assessment. As such,
neither nomogram is applicable to the preopera-
tive setting.
In the current study, we sought to develop a
nomogram that could be used in the preoperative
setting to help direct patient treatment. Factors
including tumor size, number of tumors, major
vascular invasion, and the presence of suspicious
lymph nodes on cross-sectional imaging were
included in the preoperative nomogram based
on multivariable analysis. Internal validation of
the model with a bootstrapping resample method
(n = 5,000) demonstrated good accuracy (C-in-
dex = 0.59), although---as expected---lower accuracy
than the postoperative nomograms, which incor-
porate more details from the pathologic specimen.
The graphs comparing predicted and observed
survivals at 1, 2, and 3 years did demonstrate
good calibration of the nomogram
(Supplementary Fig, A, B, and C), suggesting that
such a model may be a helpful tool to assist physi-
cians in estimating prognosis in the preoperative
setting. Importantly, the nomogram also demon-
strated significant heterogeneity in the prognosis
of patients with ICC (eg, case 1 versus case 2 versus
case 3), suggesting that the benefits of operative
resection were highly varied among patients.
While use of nomograms in the preoperative
period may be helpful, other factors in the clinical
setting may also be important to facilitate decision-
making. In particular, regret theory postulates that
Surgery
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anticipation that certain outcomes will be associ-
ated with high regret, which the provider would
like to minimize or avoid.12,13,15-17 Regret-based
DCA is particularly relevant for decisions charac-
terized by uncertainty and consequences that are
impossible to predict at the time of the decision.
After making a decision in the setting of uncer-
tainty, the physician may discover that an alterna-
tive approach would have been preferable when
he or she learns the outcomes, bringing about a
sense of loss or regret. If we hope to minimize
regret, the “best” choice would be the one associ-
ated with the least amount of regret. Importantly,
the assessment of regret of commission versus
omission can be used to compute a threshold value
at which the physician is uncertain about which
treatment strategy to adopt.11,12
Our data suggest that regret theory can be
applied to decision-making for operation versus
avoiding an operation for patients with ICC.
Given the heterogeneous nature of ICC patients,
one single treatment recommendation may not
be appropriate for all patients. In such a setting,
the physician’s preference will likely play an
important role in the treatment recommenda-
tion. Data from the current study demonstrate
that the “best” therapeutic option may include
either liver resection or no liver resection/chemo-
therapy only, depending on the provider’s pref-
erences expressed by the regret threshold values.
Our data explicitly demonstrate how either liver
resection or no liver resection/chemotherapy
alone may be recommended based on the feeling
of the provider who is participating in the deci-
sion. By accounting for personal regret about liver
resection compared with the alternative treat-
ment of chemotherapy alone, providers can arrive
at the final decision based on a combination of
the expected outcome as well as the least amount
of regret.13 In this manner, the decision-making
process includes both feelings of intuition as
well as logical analysis and deliberation.13 In
turn, physicians are forced more fully to evaluate
their personal feelings about the decision-making
process.
In addition to modeling regret-based DCA, we
also performed an assessment of regret and
decision-making based on a 50-physician survey.
As part of the survey, we asked the respondents to
express their expected regret regarding the treat-
ment decisions around 3 different clinical sce-
narios. The survey corroborated the utility of the
regret-DCA. Interestingly, the Pregs varied across a
wide range of values, emphasizing how differentphysicians can suggest different therapies. Still, the
application of the regret DCA demonstrated that
most physicians act according to the regret-
threshold model, leading to similar decisions
regarding which treatment to implement, even
when there is high uncertainty.13
For example, when combining the results of the
survey with the regret-DCA, we were able to
appreciate a good correlation between the severity
of the clinical scenario and the decision to treat
the patient. In case 3, for instance, the patient had
an advanced ICC (3 lesions, the major measuring
>5 cm, one suspicious positive lymph node, and
vascular invasion) with a survey-based expected
survival of 1 year and a threshold probability of
54% (IQR, 30–83). The regret-DCA analysis
demonstrated that even if the patient presented
with a technically resectable ICC, more than half of
physicians would withhold an operation because of
the expected regret associated with the dismal
postoperative prognosis.
Conversely, case 2 presented an early ICC (sin-
gle nodule measuring 3 cm, no suspicious positive
lymph nodes or vascular invasion at imaging). Not
surprisingly, with an expected survival of 3 years,
physicians reported a regret of omission of 100%
(IQR, 100–100) and a regret of commission of only
1% (IQR, 1–20), resulting in a threshold probabil-
ity of 5% (IQR, 4–17). The regret-DCA analysis
demonstrated that all the physicians who replied
to the survey would suggest an operation for such a
patient with an early ICC. As such, these survey
results demonstrate how the combination of
rational strategies, such as a prognostic nomo-
gram, can be incorporated with regret-DCA to
select patients with ICC for operative treatment.
The current study has several limitations. First,
as noted, the proposed preoperative nomogram
had a lower prediction ability compared with the
previously reported postoperative nomograms.6,27
While this was expected, given the inclusion of
only preoperative factors, further studies that focus
on improving the proposed preoperative model
are needed. Other limitations pertain to the
decision-making analysis itself. Operative regret
may also be dependent on a surgeon’s experience,
age, and his or her own outcomes. These factors
were not explicitly included or analyzed in our
model but were implicitly part of the surgeon
survey.
In addition, while we considered the decision to
offer ICC at a single time point, many of these
decisions happen over a period of time and may
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sion maker who incorporated individual’s level of
regret. However, in reality, decisions---including
those around level of regret---involve a multidisci-
plinary team and the patient. As such, the
approach to understanding decision-making needs
to be multifaceted. Our first goal was to define the
amount of decisional regret at the provider level
and understand how this might affect decisions.
These data are important to patients because they
demonstrate that decisions regarding their care
are not always being driven by “objective” disease-
based factors. Rather, physician perceptions/atti-
tudes often impact provider recommendations.
These data are important to patients as they allow
the patient to better understand this dynamic and
discuss with the provider how the element of
regret, error of omission versus commission, might
be at play in the decisions being discussed. The
second part of the current project, which is un-
derway, is prospectively evaluating patient regret
following an operation.
In conclusion, the regret-based DCA may pro-
vide a more appropriate framework for physicians
in the decision-making process to recommend an
operation for ICC patients. Currently, a model that
integrates a predictive tool (staging system or
nomogram) and treatment decision is not avail-
able for the management of ICC. The current
study provides an example of a regret-based DCA
that includes a simple and clinically useful nomo-
gram, while also incorporating more intuitive
factors of decision-making, such as regret. Tools
that incorporate both rational and intuitive ele-
ments are likely to be helpful in supporting
physicians in their decision to offer liver resection
to patients with ICC.
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